Susquehanna Upgrades RXO to Neutral, Lowers Price Target to $19

Benzinga Newsdesk www.benzinga.com Negative 79.1%

Neg 79.1% Neu 0% Pos 0%

Susquehanna analyst Harrison Bauer upgrades RXO (NYSE:RXO) from Negative to Neutral and lowers the price target from $20 to $19.